Sunday, December 01, 2024 4:21:08 PM
Google patent search provided the following three results:
EP3264090B12011-12-072022-05-18Belgian Volition SrlMethod for detecting nucleosome adducts
PL3213084T32014-10-292021-07-26Belgian Volition SprlMethod for the enrichment of circulating tumor dna
BR112022003546A22019-08-272022-05-17Belgian Volition SrlMethod of isolating circulating nucleosomes
EP3264090B12011-12-072022-05-18Belgian Volition SrlMethod for detecting nucleosome adducts
PL3213084T32014-10-292021-07-26Belgian Volition SprlMethod for the enrichment of circulating tumor dna
BR112022003546A22019-08-272022-05-17Belgian Volition SrlMethod of isolating circulating nucleosomes
Recent VNRX News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 08:30:19 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:13:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 08:12:43 PM
- VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update • PR Newswire (US) • 03/31/2026 08:05:00 PM
- VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium • PR Newswire (US) • 03/31/2026 12:16:00 PM
- Volition Announces Mayo Clinic Study Demonstrates Nu.Q® Concentrations are Elevated in Trauma Patients • PR Newswire (US) • 03/30/2026 12:13:00 PM
- Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference • PR Newswire (US) • 03/26/2026 12:17:00 PM
- VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update • PR Newswire (US) • 03/25/2026 08:12:00 PM
- Volition Announces Detection of Over 95% of Early-Stage Cancers • PR Newswire (US) • 03/25/2026 12:17:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:30:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:30:11 PM
- Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA • PR Newswire (US) • 03/18/2026 12:17:00 PM
- Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems • PR Newswire (US) • 03/06/2026 01:10:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:32:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:32:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:32:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:31:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:31:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:30:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:30:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:30:29 PM
- VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution • PR Newswire (US) • 02/25/2026 01:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 10:15:32 PM
